No Data
Teyi pharmaceutical group (002728.SZ): The capacity of the modern traditional chinese medicine product line expansion and technological upgrade project is planned to be gradually released starting next year.
Gelonghui reported on December 4 that teyi pharmaceutical group (002728.SZ) stated on the investor interaction platform that the modernization of the traditional chinese medicine product line expansion and technology upgrade project has completed the renovation of the Chinese pill production workshop, the comprehensive formulation workshop and testing building have been constructed, with some already in use and others undergoing the installation of related equipment. Production capacity is planned to be gradually released starting next year.
Teyi Pharmaceutical Group (002728.SZ): Plans to change part of the use of raised funds.
Gelonghui December 2nd | Teyi Pharmaceutical Group (002728.SZ) announced that according to the company's 2023 simple procedure refinancing to raise funds for investment project progress, and combined with the current market environment, the company's own development global strategy and future development plan, in order to improve the efficiency of fund raising and investment return, after careful research and analysis, the company plans to change some of the uses of the funds raised, the unused balance of the raised funds for the 'Modern traditional chinese medicine decoction piece construction project' of RMB 210.3566 million to be changed to implement the company's 2021 non-public offering investment project 'modern traditional chinese medicine product line expansion'.
Teyi Pharmaceutical Group (002728.SZ): The company currently has no AI pharmaceutical business.
gelonhui November 20th | teyi pharmaceutical group (002728.SZ) stated on the investor interaction platform that the company currently has no business in AI pharmaceuticals.
Subdued Growth No Barrier To Teyi Pharmaceutical Group Co.,Ltd (SZSE:002728) With Shares Advancing 27%
teyi pharmaceutical group (002728.SZ): has accumulated repurchased 2.49% of the shares
Gelonghui November 1st | Teyi Pharmaceutical Group (002728.SZ) announced that, as of October 31, 2024, the company repurchased 12,718,084 shares of the company through the Shenzhen Stock Exchange trading system using centralized bidding trading method, accounting for 2.49% of the company's current total share capital. The highest price of the repurchase transaction is 8.03 yuan/share, the lowest price is 6.79 yuan/share, and the total amount of funds paid is RMB 93.85025 million (excluding relevant transaction costs).
Teyi Pharmaceutical: Report for the third quarter of 2024
Improved Earnings Required Before Teyi Pharmaceutical Group Co.,Ltd (SZSE:002728) Stock's 29% Jump Looks Justified
